Microbot Medical Inc. (MBOT)
Stock Price:
$6.77 USD
-0.13 (-1.88%)
Updated Aug 11, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
48.09M |
| Revenue (ttm) |
n/a |
| Net Income (ttm) |
-7.49M |
| Shares Out |
7.10M |
| EPS (ttm) |
-1.49 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Aug 11, 2020 |
| Last Price |
$6.77 |
| Previous Close |
$6.90 |
| Change ($) |
-0.13 |
| Change (%) |
-1.88% |
| Day's Open |
6.99 |
| Day's Range |
6.59 - 6.99 |
| Day's Volume |
180,445 |
| 52-Week Range |
4.30 - 20.15 |
More Stats
| Market Cap |
48.09M |
| Enterprise Value |
19.30M |
| Earnings Date (est) |
Aug 18, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
7.10M |
| Float |
6.80M |
| EPS (basic) |
-1.54 |
| EPS (diluted) |
-1.49 |
| FCF / Share |
-1.35 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
201,805 |
| Short Ratio |
1.58 |
| Short % of Float |
3.05% |
| Beta |
5.61 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
n/a |
| PB Ratio |
1.70 |
| Revenue |
n/a |
| Operating Income |
-7.49M |
| Net Income |
-7.49M |
| Free Cash Flow |
-9.67M |
| Net Cash |
28.79M |
| Net Cash / Share |
4.05 |
| Gross Margin |
n/a |
| Operating Margin |
n/a |
| Profit Margin |
n/a |
| FCF Margin |
n/a |
| ROA |
-20.70% |
| ROE |
-38.51% |
| ROIC |
n/a |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (1)
| Buy |
1 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Low
19.0
Current: $6.77
High
19.0
Target: 19.00
*Average 12-month price target from 1 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|
| Revenue | - | - | - | - | - | 1.01 | 0.17 | 0.49 | 1.22 | 1.43 |
| Revenue Growth | - | - | - | - | - | 487.58% | -64.82% | -59.88% | -14.46% | - |
| Gross Profit | - | - | - | - | - | 1.01 | 0.17 | 0.49 | 1.01 | 1.26 |
| Operating Income | -7.24 | -7.24 | -5.27 | -9.64 | -0.92 | -30.91 | -28.09 | -21.91 | -28.08 | -29.36 |
| Net Income | -7.25 | -7.26 | -7.59 | -9.66 | -0.92 | -32.74 | -26.44 | -28.49 | -21.33 | -25.24 |
| Shares Outstanding | 4.27 | 2.90 | 2.18 | 0.95 | 0.06 | 0.04 | 0.03 | 0.02 | 0.01 | 0.01 |
| Earnings Per Share | -1.70 | -2.41 | -2.76 | -6.00 | -0.60 | -858.60 | -988.20 | -1,603.80 | -2,430.00 | -3,321.00 |
| Operating Cash Flow | -6.45 | -5.31 | -4.86 | -0.79 | -0.77 | -27.35 | -23.32 | -19.87 | -22.06 | -24.52 |
| Capital Expenditures | 0.04 | -0.22 | -0.06 | -0.03 | - | -0.90 | -4.64 | -0.07 | -0.30 | -0.92 |
| Free Cash Flow | -6.41 | -5.53 | -4.91 | -0.81 | -0.77 | -28.25 | -27.96 | -19.94 | -22.36 | -25.44 |
| Cash & Equivalents | 35.65 | 5.26 | 10.81 | 2.71 | 0.44 | 24.99 | 30.59 | 22.37 | 16.59 | 19.90 |
| Total Debt | 0.90 | - | - | 0.08 | 0.42 | 15.05 | 13.08 | 0.35 | 0.54 | 0.78 |
| Net Cash / Debt | 34.75 | 5.26 | 10.81 | 2.63 | 0.02 | 9.94 | 17.50 | 22.02 | 16.05 | 19.11 |
| Assets | 37.13 | 6.09 | 11.02 | 3.37 | 0.53 | 32.43 | 41.56 | 30.17 | 25.21 | 30.60 |
| Liabilities | 5.59 | 4.76 | 0.56 | 1.17 | 0.59 | 26.56 | 26.60 | 16.19 | 14.48 | 15.12 |
| Book Value | 31.54 | 1.33 | 9.96 | 1.70 | -0.06 | 5.87 | 14.95 | 13.98 | 10.73 | 15.48 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Microbot Medical Inc. |
| Country |
United States |
| Employees |
10 |
| CEO |
Harel Gadot |
Stock Information
| Ticker Symbol |
MBOT |
| Stock Exchange |
NASDAQ |
| Unique Identifier |
NASDAQ: MBOT |
Description
Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable self-propelled locomotive device to treat capabilities within tubular lumens, such as the blood vessels, respiratory, and the urinary and GI tracts; a combination of a guidewire and microcatheter technologies that are used for endoluminal surgery; and maneuver guidewire, microcatheters, and over-the-wire devices within the body's vasculature. It has 37 issued/allowed patents and 15 patent applications pending worldwide. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.